Suzanne Izard
Impact in
- Infectious Diseases top 5%
- Viral Infections and Outbreaks Research
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
-
- HIV Research and Treatment
Papers in
-
- Viral Infections and Outbreaks Research 8
- HIV/AIDS drug development and treatment 6
- HIV/AIDS Research and Interventions 3
-
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Hepatitis B Virus Studies 1
- Co-authors
- Françis Guillemin (1 shared paper)Bernard Taverne (1 shared paper)Abdoulaye Fodé Touré (1 shared paper)Isabelle Charreau (1 shared paper)François Raffi (1 shared paper)Éric Delaporte (4 shared papers)Yves‐Marie Pers (1 shared paper)Moumié Barry (1 shared paper)
In The Last Decade
Suzanne Izard
15 papers receiving 335 citations
Peers
Comparison fields: 5 of 37
- Infectious Diseases 276
- Virology 10
- Ophthalmology 19
- Clinical Psychology 27
- Applied Microbiology and Biotechnology 2
Countries citing papers authored by Suzanne Izard
This map shows the geographic impact of Suzanne Izard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Izard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Izard more than expected).
Fields of papers citing papers by Suzanne Izard
This network shows the impact of papers produced by Suzanne Izard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Izard. The network helps show where Suzanne Izard may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne Izard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 106 | |
| 2 | 2017 | 63 | |
| 3 | 2016 | 54 | |
| 4 | 2001 | 21 | |
| 5 | 2021 | 19 | |
| 6 | 2021 | 18 | |
| 7 | 2018 | 17 | |
| 8 | 2017 | 15 | |
| 9 | 2016 | 13 | |
| 10 | Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial | 2016 | 5 |
| 11 | 2019 | 5 | |
| 12 | 2019 | 5 | |
| 13 | Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results | 2017 | 2 |
| 14 | 2023 | 2 | |
| 15 | 2017 | 1 | |
| 16 | 2025 | 0 |
About Suzanne Izard
Suzanne Izard is a scholar working on Infectious Diseases, Epidemiology, Economics and Econometrics, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 16 papers that have together received 346 indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (8 papers), HIV/AIDS drug development and treatment (6 papers), HIV/AIDS Research and Interventions (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Hepatitis B Virus Studies (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Infectious Diseases (276 citations), Virology (10 citations), Ophthalmology (19 citations), Clinical Psychology (27 citations) and Applied Microbiology and Biotechnology (2 citations). Suzanne Izard has collaborated with scholars based in France, Guinea and Senegal. Frequent co-authors include Françis Guillemin, Bernard Taverne, Abdoulaye Fodé Touré, Isabelle Charreau, François Raffi, Éric Delaporte, Yves‐Marie Pers, Moumié Barry, Christian Rabaud and Catherine Leport. Their work appears in journals such as Lara D. Veeken, Journal of the International AIDS Society, Open Forum Infectious Diseases, Scandinavian Journal of Infectious Diseases and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.